folder Filed in Culture, Policy
Psychedelics - Pathway to Legalization
Lawyers, drug policy experts, doctors and scientists weigh in on the future of psychedelics in America
Peter Cervieri access_time 2 min read

Join a group of lawyers, drug policy experts, scientist and doctors researching and prescribing psychedelics for a discussion on psychedelics.

Psychedelics, Pathway to Legalization – Video 01

Omar Figueroa kicks off our Multidisciplinary Association for Psychedelic Studies (MAPS) / Future Cannabis Project psychedelics event with a history lesson on psychedelics, their use in society, the drug war and its effect on psychedelics, and current federal and state laws related to psychedelics.

Psychedelics, Pathway to Legalization – Video 02

Omar Figueroa, Cannabis activist and attorney, and Natalie Ginsberg, Multidisciplinary Association for Psychedelic Studies (MAPS) talk about psychedelic policy and law.

Psychedelics, Pathway to Legalization – Video 03

Dr. Cole Marta and Ashley Booth are working on a Multidisciplinary Association for Psychedelic Studies (MAPS) funded MDMA-Assisted Psychotherapy study.

They talk about their research with Omar Figueroa, Law Offices of Omar Figueroa and Natalie Lyla Ginsberg, Policy & Advocacy Director, Multidisciplinary Association for Psychedelic Studies (MAPS)

Phase 3 Trials: FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Psychotherapy for PTSD, Agrees on Special Protocol Assessment Preliminary studies have shown that MDMA in conjunction with psychotherapy can help people overcome PTSD, and possibly other disorders as well. MDMA is known for increasing feelings of trust and compassion towards others, which could make an ideal adjunct to psychotherapy for PTSD.

MAPS is studying whether MDMA-assisted psychotherapy can help heal the psychological and emotional damage caused by sexual assault, war, violent crime, and other traumas. MAPS also sponsored completed studies of MDMA-assisted psychotherapy for autistic adults with social anxiety, and MDMA-assisted psychotherapy for anxiety related to life-threatening illnesses.

This event took place on November 26, 6-9pm, Los Angeles

Speakers
Omar Figueroa
, Cannabis Attorney
Natalie Ginsberg
, Director of Policy, MAPS (Multidisciplinary Association for Psychedelic Studies)
Dr. Cole Marta
, Ketamine Assisted Psychotherapy Clinic, principal investigator at the Los Angeles site in the phase 3 trial of MDMA as a treatment for PTSD
Ashley Booth
, Founder, Aware Project: Rethinking Psychedelics, InnerSpace Integration

Thanks to our partners, friends and supporters

MAPS (Multidisciplinary Association for Psychedelic Studies)